1,735
Views
1
CrossRef citations to date
0
Altmetric
Articles

Evaluation of the Forsvall biopsy needle in an ex vivo model of transrectal prostate biopsy – a novel needle design with the objective to reduce the risk of post-biopsy infection

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 227-234 | Received 12 Feb 2021, Accepted 19 Apr 2021, Published online: 17 May 2021

References

  • Liss MA, Ehdaie B, Loeb S, et al. An update of the American Urological Association White Paper on the prevention and treatment of the more common complications related to prostate biopsy. J Urol. 2017;198(2):329–334.
  • Loeb S, Vellekoop A, Ahmed HU, et al. Systematic review of complications of prostate biopsy. Eur Urol. 2013;64(6):876–892.
  • Liss MA, Johnson JR, Porter SB, et al. Clinical and microbiological determinants of infection after transrectal prostate biopsy. Clin Infect Dis. 2015;60(7):979–987.
  • Johansen TEB, Zahl PH, Baco E, et al. Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry. World J Urol. 2020;38(1):17–26..
  • Liss MA, Taylor SA, Batura D, et al. Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy. J Urol. 2014;192(6):1673–1678.
  • Mottet N, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2021;79(2):243–262.
  • Williamson DA, Barrett LK, Rogers BA, et al. Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli. Clin Infect Dis. 2013;57(2):267–274.
  • Raman JD, Lehman KK, Dewan K, et al. Povidone iodine rectal preparation at time of prostate needle biopsy is a simple and reproducible means to reduce risk of procedural infection. J Vis Exp. 2015;(103):52670.
  • Knop K, Hoogenboom R, Fischer D, et al. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew Chem Int Ed Engl. 2010;49(36):6288–6308.
  • Song DY, Herfarth KK, Uhl M, et al. A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes. Int J Radiat Oncol Biol Phys. 2013;87(1):81–87.
  • Emilsson G, Schoch RL, Feuz L, et al. Strongly stretched protein resistant poly(ethylene glycol) brushes prepared by grafting-to. ACS Appl Mater Interfaces. 2015;7(14):7505–7515.
  • Klar E, Rahmanian PB, Bucker A, et al. Acute mesenteric ischemia: a vascular emergency. Dtsch Arztebl Int. 2012; 109(14):249–256.
  • Goldman E, Green LH. Practical handbook of microbiology. Boca Raton: CRC Press; 2009.
  • Pilatz A, Veeratterapillay R, Koves B, et al. Update on strategies to reduce infectious complications after prostate biopsy. Eur Urol Focus. 2019;5(1):20–28.
  • Forsvall A, Fisher J, Wagenius M, et al. Prostate biopsy quality and patient experience with the novel Forsvall biopsy needle – a randomized controlled non-inferiority trial. Scandi J Urol. 2021;55(3):235–241.